Literature DB >> 10709777

Target-controlled infusion systems: role in anaesthesia and analgesia.

M C van den Nieuwenhuyzen1, F H Engbers, J Vuyk, A G Burm.   

Abstract

Drug delivery by target-controlled infusion (TCI) allows automatic adjustments of the infusion rate of a drug to maintain a desired target concentration. Since drug effect is more closely related to blood concentration than to infusion rate, drug delivery via TCI is capable of creating stable blood concentrations of intravenous anaesthetics and analgesics. In this article the concept and history of TCI are described. The rational administration of TCI requires an appropriate pharmacokinetic data set and knowledge of the concentration-effect relationship; therefore, general pharmacokinetic and pharmacodynamic aspects of intravenous anaesthetics and analgesics are also addressed. Intraoperative investigations have demonstrated that TCI drug delivery allows rapid titration to a desired effect. The use of TCI for postoperative analgesia is still experimental, but TCI can, in part, overcome the disadvantages associated with continuous infusions and patient-controlled analgesia regimens in the postoperative period. Although TCI is capable of creating stable blood concentrations, when the target concentration is changed the resulting effect correlates better with a theoretical effect site concentration. The efficacy of TCI systems that can perform effect-site steering are still to be explored.

Entities:  

Mesh:

Year:  2000        PMID: 10709777     DOI: 10.2165/00003088-200038020-00003

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  52 in total

Review 1.  Development of the technology for 'Diprifusor' TCI systems.

Authors:  J M Gray; G N Kenny
Journal:  Anaesthesia       Date:  1998-04       Impact factor: 6.955

2.  Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients.

Authors:  P O Maitre; S Vozeh; J Heykants; D A Thomson; D R Stanski
Journal:  Anesthesiology       Date:  1987-01       Impact factor: 7.892

3.  Predictive accuracy of continuous alfentanil infusion in volunteers: variability of different pharmacokinetic sets.

Authors:  L Barvais; F Cantraine; A D'Hollander; E Coussaert
Journal:  Anesth Analg       Date:  1993-10       Impact factor: 5.108

4.  Pharmacokinetics as applied to total intravenous anaesthesia. Theoretical considerations.

Authors:  H Schwilden; J Schüttler; H Stoekel
Journal:  Anaesthesia       Date:  1983-07       Impact factor: 6.955

5.  Pharmacokinetic model-driven infusion of fentanyl: assessment of accuracy.

Authors:  P S Glass; J R Jacobs; L R Smith; B Ginsberg; T J Quill; S A Bai; J G Reves
Journal:  Anesthesiology       Date:  1990-12       Impact factor: 7.892

6.  Postoperative patient-controlled analgesia with alfentanil: analgesic efficacy and minimum effective concentrations.

Authors:  K A Lehmann; N Ribbert; G Horrichs-Haermeyer
Journal:  J Pain Symptom Manage       Date:  1990-08       Impact factor: 3.612

7.  Pharmacodynamics of propofol in female patients.

Authors:  J Vuyk; F H Engbers; H J Lemmens; A G Burm; A A Vletter; M P Gladines; J G Bovill
Journal:  Anesthesiology       Date:  1992-07       Impact factor: 7.892

8.  Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia.

Authors:  A Shafer; V A Doze; S L Shafer; P F White
Journal:  Anesthesiology       Date:  1988-09       Impact factor: 7.892

9.  Comparative pharmacokinetics of fentanyl and alfentanil.

Authors:  S Bower; C J Hull
Journal:  Br J Anaesth       Date:  1982-08       Impact factor: 9.166

10.  Patient-maintained analgesia with target-controlled alfentanil infusion after cardiac surgery: a comparison with morphine PCA.

Authors:  M R Checketts; C J Gilhooly; G N Kenny
Journal:  Br J Anaesth       Date:  1998-06       Impact factor: 9.166

View more
  3 in total

1.  Bayesian probabilistic network modeling of remifentanil and propofol interaction on wakeup time after closed-loop controlled anesthesia.

Authors:  Ulrich Bothtner; Stewart E Milne; Gavin N C Kenny; Michael Georgieff; Stefan Schraag
Journal:  J Clin Monit Comput       Date:  2002-01       Impact factor: 2.502

2.  External Validation of a Recently Developed Population Pharmacokinetic Model for Hydromorphone During Postoperative Pain Therapy.

Authors:  Harald Ihmsen; Doris Rohde; Jürgen Schüttler; Christian Jeleazcov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

3.  Blood-brain barrier transport of morphine in patients with severe brain trauma.

Authors:  Per Ederoth; Karin Tunblad; René Bouw; C Johan F Lundberg; Urban Ungerstedt; Carl-Henrik Nordström; Margareta Hammarlund-Udenaes
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.